LGC Genomics invests in new laboratory in Boston, US
The new laboratory will initially focus on providing genotyping and nucleic acid extraction services using the company’s KASPTM and sbeadex® technologies in combination with the unique SNPline genotyping instrumentation solution.
Simon Parsons, LGC Group CFO and LGC Genomics Divisional Director commented: “We are delighted to be announcing the opening of our new Cumming’s Centre laboratory. This facility is an important element of our expansion programme in North America. Our expanded laboratory service capacity will enable us to deliver solutions to those groups looking to expand internal capacity through outsourcing and will also enable us to deliver improved products for customers conducting their own genomics research and analysis. The delivery of high-quality genomics products and services is fundamental to tackling many of the key global issues confronting science such as sustainable food production and improving health. The new laboratory offers a significant opportunity for us to support these important areas of research across North America”
Most read news
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.